180 related articles for article (PubMed ID: 36980202)
1. B7H4 Expression Is More Frequent in MSS Status Colorectal Cancer and Is Negatively Associated with Tumour Infiltrating Lymphocytes.
Dawidowicz M; Kula A; Mielcarska S; Kiczmer P; Skiba H; Krygier M; Chrabańska M; Piecuch J; Szrot M; Robotycka J; Ochman B; Strzałkowska B; Czuba Z; Świętochowska E; Waniczek D
Cells; 2023 Mar; 12(6):. PubMed ID: 36980202
[TBL] [Abstract][Full Text] [Related]
2. B7H3 Role in Reshaping Immunosuppressive Landscape in MSI and MSS Colorectal Cancer Tumours.
Mielcarska S; Dawidowicz M; Kula A; Kiczmer P; Skiba H; Krygier M; Chrabańska M; Piecuch J; Szrot M; Ochman B; Robotycka J; Strzałkowska B; Czuba Z; Waniczek D; Świętochowska E
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370746
[TBL] [Abstract][Full Text] [Related]
3. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status.
Michael-Robinson JM; Biemer-Hüttmann A; Purdie DM; Walsh MD; Simms LA; Biden KG; Young JP; Leggett BA; Jass JR; Radford-Smith GL
Gut; 2001 Mar; 48(3):360-6. PubMed ID: 11171826
[TBL] [Abstract][Full Text] [Related]
4. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells.
Jing ZL; Liu GL; Zhou N; Xu DY; Feng N; Lei Y; Ma LL; Tang MS; Tong GH; Tang N; Deng YJ
Sci Rep; 2024 Mar; 14(1):6053. PubMed ID: 38480774
[TBL] [Abstract][Full Text] [Related]
6. Presence of Tim3
Klapholz M; Drage MG; Srivastava A; Anderson AC
J Pathol; 2022 Jun; 257(2):186-197. PubMed ID: 35119692
[TBL] [Abstract][Full Text] [Related]
7. Overexpression and Role of HHLA2, a Novel Immune Checkpoint, in Colorectal Cancer.
Kula A; Dawidowicz M; Mielcarska S; Kiczmer P; Skiba H; Krygier M; Chrabańska M; Piecuch J; Szrot M; Robotycka J; Ochman B; Strzałkowska B; Czuba Z; Świętochowska E; Waniczek D
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982953
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory receptor CD94/NKG2A on CD8
Eugène J; Jouand N; Ducoin K; Dansette D; Oger R; Deleine C; Leveque E; Meurette G; Podevin J; Matysiak T; Bennouna J; Bezieau S; Volteau C; Thomas WEA; Chetritt J; Kerdraon O; Fourquier P; Thibaudeau E; Dumont F; Mosnier JF; Toquet C; Jarry A; Gervois N; Bossard C
Mod Pathol; 2020 Mar; 33(3):468-482. PubMed ID: 31409873
[TBL] [Abstract][Full Text] [Related]
9. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic.
Phillips SM; Banerjea A; Feakins R; Li SR; Bustin SA; Dorudi S
Br J Surg; 2004 Apr; 91(4):469-75. PubMed ID: 15048750
[TBL] [Abstract][Full Text] [Related]
10. B7H4 expression in tumor cells impairs CD8 T cell responses and tumor immunity.
Zhou L; Ruan M; Liu Y; Zhu Y; Fu D; Wu K; Zhang Q
Cancer Immunol Immunother; 2020 Feb; 69(2):163-174. PubMed ID: 31848656
[TBL] [Abstract][Full Text] [Related]
11. Microbiota-dependent activation of the myeloid calcineurin-NFAT pathway inhibits B7H3- and B7H4-dependent anti-tumor immunity in colorectal cancer.
Peuker K; Strigli A; Tauriello DVF; Hendricks A; von Schönfels W; Burmeister G; Brosch M; Herrmann A; Krüger S; Nitsche J; Južnić L; Geissler MM; Hiergeist A; Gessner A; Wirbel J; Ponnudurai RP; Tunger A; Wehner R; Stange DE; Weitz J; Aust DE; Baretton GB; Schmitz M; Röcken C; Hampe J; Hinz S; Zeller G; Chavakis T; Schafmayer C; Batlle E; Zeissig S
Immunity; 2022 Apr; 55(4):701-717.e7. PubMed ID: 35364006
[TBL] [Abstract][Full Text] [Related]
12. Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer.
Thibaudin M; Limagne E; Hampe L; Ballot E; Truntzer C; Ghiringhelli F
Cancer Immunol Immunother; 2022 Oct; 71(10):2549-2563. PubMed ID: 35292828
[TBL] [Abstract][Full Text] [Related]
13. Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.
Zaravinos A; Roufas C; Nagara M; de Lucas Moreno B; Oblovatskaya M; Efstathiades C; Dimopoulos C; Ayiomamitis GD
J Exp Clin Cancer Res; 2019 Aug; 38(1):364. PubMed ID: 31429779
[TBL] [Abstract][Full Text] [Related]
14. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
[TBL] [Abstract][Full Text] [Related]
15. Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer.
Akin Telli T; Bregni G; Vanhooren M; Saude Conde R; Hendlisz A; Sclafani F
Cancer Treat Rev; 2022 Nov; 110():102460. PubMed ID: 36058142
[TBL] [Abstract][Full Text] [Related]
16. Co-inhibitor expression on tumor infiltrating and splenic lymphocytes after dual checkpoint inhibition in a microsatellite stable model of colorectal cancer.
Slovak RJ; Park HJ; Kamp WM; Ludwig JM; Kang I; Kim HS
Sci Rep; 2021 Mar; 11(1):6956. PubMed ID: 33772035
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
[TBL] [Abstract][Full Text] [Related]
18. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability.
Prall F; Dührkop T; Weirich V; Ostwald C; Lenz P; Nizze H; Barten M
Hum Pathol; 2004 Jul; 35(7):808-16. PubMed ID: 15257543
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis.
De Smedt L; Lemahieu J; Palmans S; Govaere O; Tousseyn T; Van Cutsem E; Prenen H; Tejpar S; Spaepen M; Matthijs G; Decaestecker C; Moles Lopez X; Demetter P; Salmon I; Sagaert X
Br J Cancer; 2015 Jul; 113(3):500-9. PubMed ID: 26068398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
